These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 3488188)
1. Clinical features fail to distinguish respiratory infections caused by Branhamella catarrhalis from those caused by Haemophilus influenzae. Forward KR Can J Infect Dis; 1992 Jan; 3(1):19-22. PubMed ID: 22451757 [TBL] [Abstract][Full Text] [Related]
2. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Murphy TF; Brauer AL; Grant BJ; Sethi S Am J Respir Crit Care Med; 2005 Jul; 172(2):195-9. PubMed ID: 15805178 [TBL] [Abstract][Full Text] [Related]
3. Moraxella catarrhalis: from emerging to established pathogen. Verduin CM; Hol C; Fleer A; van Dijk H; van Belkum A Clin Microbiol Rev; 2002 Jan; 15(1):125-44. PubMed ID: 11781271 [TBL] [Abstract][Full Text] [Related]
4. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Sethi S; Murphy TF Clin Microbiol Rev; 2001 Apr; 14(2):336-63. PubMed ID: 11292642 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Bakaletz LO; Murwin DM; Billy JM Infect Immun; 1995 Oct; 63(10):4188-90. PubMed ID: 7558341 [TBL] [Abstract][Full Text] [Related]
9. Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp. Vaneechoutte M; Verschraegen G; Claeys G; van den Abeele AM J Clin Microbiol; 1988 Dec; 26(12):2544-8. PubMed ID: 3147992 [TBL] [Abstract][Full Text] [Related]
10. Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis. Brown BA; Wallace RJ; Flanagan CW; Wilson RW; Luman JI; Redditt SD Antimicrob Agents Chemother; 1989 Sep; 33(9):1631-3. PubMed ID: 2510597 [TBL] [Abstract][Full Text] [Related]
11. Branhamella catarrhalis: an organism gaining respect as a pathogen. Catlin BW Clin Microbiol Rev; 1990 Oct; 3(4):293-320. PubMed ID: 2121328 [TBL] [Abstract][Full Text] [Related]
12. Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Verghese A; Roberson D; Kalbfleisch JH; Sarubbi F Antimicrob Agents Chemother; 1990 Jun; 34(6):1041-4. PubMed ID: 2118322 [TBL] [Abstract][Full Text] [Related]
13. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Pollard JA; Wallace RJ; Nash DR; Luman JI; Wilson RW Drugs; 1986; 31 Suppl 3():103-8. PubMed ID: 3488188 [TBL] [Abstract][Full Text] [Related]
14. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Slevin NJ; Aitken J; Thornley PE Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094 [TBL] [Abstract][Full Text] [Related]
15. A 2-year survey of Branhamella catarrhalis in a general hospital. Smith JM; Lockwood BM J Hosp Infect; 1986 May; 7(3):277-82. PubMed ID: 2873174 [TBL] [Abstract][Full Text] [Related]
16. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Nicotra B; Rivera M; Luman JI; Wallace RJ Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981 [TBL] [Abstract][Full Text] [Related]